Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial CarcinomaThomas Powles, Petros Grivas, Haralabos P. Kalofonos et al.|New England Journal of Medicine|2020Cited by 1.5k
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-UpThomas Powles, Petros Grivas, Se Hoon Park et al.|Journal of Clinical Oncology|2023Cited by 210
Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid TumorsToshio Shimizu, Anthony W. Tolcher, Patricia LoRusso et al.|Clinical Cancer Research|2014Cited by 82